Botulism Vaccine
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B (NCT00764634) | DynPort Vaccine Company LLC, A GDIT Company | 2008-09-01 |
Track Botulism Vaccine automatically
Every clearance here is in the API, with alerts when new ones post.